Spatial OMICS Market Size To Reach $484.22 Million By 2028 | CAGR: 10.0%: Grand View Research, Inc.

USA - English

News provided by

Jul 13, 2021, 05:05 ET

SAN FRANCISCO, July 13, 2021 /PRNewswire/ -- The global spatial OMICS market size is expected to reach USD 484.22 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.00% from 2021 to 2028. The COVID-19 pandemic slowed down many industries worldwide. However, this market did not face the extensive negative impact of the pandemic.

Key Insights & Findings:

By technology, spatial transcriptomics accounted for the largest share in 2020 and is projected to maintain its dominance throughout the forecast period as most of the available products are based on mRNA analysis for positional information
In terms of product, the consumables segment held the largest revenue share in 2020 owing to the frequent purchase of reagents and probes to run instruments
Based on workflow, the instrumental analysis segment dominated the market in 2020 owing to the technological advancements and launch of novel products in the market
The fresh frozen sample type is anticipated to expand at a lucrative CAGR from 2021 to 2028 as fresh frozen tissue preserves the native state of proteins and hence are adopted in spatial proteomics analysis
On the basis of end use, the academic and translational research institutes dominated the market in 2020 owing to an increase in biomedical research in academic universities

Read 197 page market research report, "Spatial OMICS Market Size, Share & Trends Analysis Report By Technology (Transcriptomics, Genomics, Proteomics), By Product, By Workflow, By Sample Type, By End Use, By Region, And Segment Forecasts, 2021 - 2028", by Grand View Research

Startups and well-established players continued their product development and launched novel solutions, democratized their offerings beyond innovators, and engaged in mergers & acquisitions. The spatial OMICS field originated from hyperplexed imaging; however, key players have shifted toward the development of spatial transcriptomics solutions and products.

Rapid advances in the sequencing of tissues, genes, and single cells have resulted in the emergence of spatial genomic sequencing. Spatial OMICS techniques offer quantitative gene expression data and visualization of DNA and RNA mapping within tissue sections. The development of novel technologies for spatial OMICS is anticipated to create lucrative opportunities for the fields of translational research as well as diagnostics.

The spatial genomics technology segment is expected to expand at the fastest CAGR throughout the forecast period owing to a rise in the launch of novel platforms. The integration of high-throughput solutions in transcriptomics, genomics, and proteomics studies has enabled determining the link between disease occurrence and genome position.

The instruments product held the second-largest share in 2020 owing to the launch of new automated solutions for spatial OMIC studies. For instance, in March 2021, Rebus Biosystems launched the new Rebus Esper spatial omics platform for a better understanding of tissue biology. The new integrated and automated instrument delivers quantitative single-cell, single-molecule data with subcellular resolution and spatial context by using advanced fluidics, imaging, chemistry, and bioinformatics solutions.

The fresh frozen sample type is expected to witness significant growth over the forecast period. The advantages of fresh frozen samples in proteomics are validated by several research studies. For instance, in March 2021, a study concluded that Filter Aided Sample Preparation (FASP) technique yielded 20% more protein identifications by using fresh frozen samples than formalin-fixed, paraffin-embedded (FFPE) samples.

North America held the largest share in 2020 owing to an increase in focus on translational research, rise in government support for genomics and sequencing technologies, high demand for personalized medicine, and the presence of a substantial number of translational and academic research organizations.

Grand View Research has segmented the global spatial OMICS market on the basis of technology, product, workflow, sample type, end use, and region:

Spatial OMICS Technology Outlook (Revenue, USD Million, 2017 - 2028)

Spatial Transcriptomics

Sequencing-based Methods

Laser capture microdissection (LCM), by tissue type

FFPE tissue samples

Others

Transcriptome in-vivo analysis (TIVA)
In situ sequencing
Microtomy sequencing

IHC
Microscopy-based RNA Imaging Techniques, by methods

Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)
Padlock Probes/ Rolling Circle Amplification
Branched DNA probes

Spatial Genomics

FISH
Microscopy-based Live DNA Imaging
Genome Perturbation Tools
Massively-parallel Sequencing
Biochemical Techniques
Others

Spatial Proteomics

Imaging Techniques

Microscopy
Multiplexed Ion Beam Imaging

Mass Spectrometry
Immunofluorescence Techniques
Centrifugation Techniques
Others

Spatial OMICS Product Outlook (Revenue, USD Million, 2017 - 2028)

Instruments

By Mode

Automated
Semi-automated
Manual

By Type

Sequencing Platforms
IHC
Microscopy
Flow Cytometry
Mass Spectrometry
Others

Consumables
Software

Bioinformatics tools
Imaging tools
Storage and management databases

Spatial OMICS Workflow Outlook (Revenue, USD Million, 2017 - 2028)

Sample Preparation
Instrumental Analysis
Data Analysis

Spatial OMICS Sample Type Outlook (Revenue, USD Million, 2017 - 2028)

FFPE
Fresh Frozen

Spatial OMICS End-use Outlook (Revenue, USD Million, 2017 - 2028)

Academic & Translational Research Institutes
Pharmaceutical and Biotechnology Companies

Spatial OMICS Regional Outlook (Revenue, USD Million, 2017 - 2028)

North America

U.S.
Canada

Europe

Germany
U.K.
France
Spain
Italy
Netherlands

Asia Pacific

Japan
China
India
South Korea
Australia
Singapore

Latin America

Brazil

South Africa

List of Key Players of Spatial OMICS Market

10x Genomics
Dovetail Genomics
S2 Genomics, Inc.
NanoString Technologies, Inc.
Seven Bridges Genomics
PerkinElmer, Inc.
Bio-Techne
Danaher Corporation
IonPath, Inc.
Millennium Science Pty Ltd.
Akoya Biosciences, Inc.
Fluidigm Corporation
Diagenode Diagnostics
Biognosys AG
Rebus Biosystems
Ultivue, Inc.
Vizgen Corp.
BioSpyder Technologies
Bruker
Brooks Automation, Inc.

Browse through Grand View Research's coverage of the Global Biotechnology Industry:

Proteomics Market – The global proteomics market size is expected to reach over USD 24.8 billion by 2024. The growing incidence of target diseases such as cancer, diabetes, and cardiovascular is expected to be the major factor for market growth.
Bioinformatics Market – The global bioinformatics market is expected to reach USD 13.47 billion by 2020. It is expected to grow at a CAGR of 21.2% from 2014 to 2020.
Spatial Genomics & Transcriptomics Market – The global spatial genomics and transcriptomics market size is expected to reach USD 381.3 million by 2028. It is expected to expand at a CAGR of 11.1% from 2021 to 2028.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter